Despite the clear need for better therapies for psychiatric disorders such as depression and schizophrenia, novel drugs — particularly those that could revolutionize treatment — have been rare in recent years. Following a symposium in which the underlying reasons for this problem were discussed, a group of experts from across the field of neuroscience highlight key advances in our understanding of psychiatric disorders, and propose steps that can be taken to improve the effectiveness of drug discovery in this field.
- Yves Agid
- György Buzsáki
- Daniel Weinberger
